Portfolio company
Rodin Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops small molecule therapies targeting epigenetic mechanisms to treat neurodegenerative and cognitive disorders for patients with diseases like Alzheimer's.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
NeurOdys Therapeutics
This biotechnology company develops small molecule therapies for patients with neurodegenerative conditions such as Alzheimer's and Parkinson's diseases.
Revivio Therapeutics
This clinical-stage biotechnology company develops small molecule therapeutics for patients with neurodegenerative diseases, including Alzheimer's disease and mild cognitive impairment.
Souvien Therapeutics
This biotechnology company develops therapeutic agents targeting epigenetic mechanisms to treat neurodegenerative diseases for patients with age-related conditions like dementia.
Cognition Therapeutics
This company develops oral small-molecule medications for patients with neurodegenerative disorders such as Alzheimer's disease and dementia with Lewy bodies.
AstronauTx
This biotechnology company develops small-molecule drugs targeting astrocyte biology to treat patients with Alzheimer's disease and other neurodegenerative disorders.
CuraSen Therapeutics
This biopharmaceutical company develops small molecule drugs to treat patients with neurodegenerative disorders, such as Parkinson's and Alzheimer's disease.
AZ Therapies
This biopharmaceutical company develops therapies for neurodegenerative diseases, including Alzheimer's disease and ischaemic stroke, to treat patients and improve their cognitive health.
PharmatrophiX
The company develops small-molecule therapies targeting neurotrophin receptors for patients with Alzheimer's disease and other neurodegenerative disorders.
